Lack of an effect of a novel β3-adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: A double-blind, placebo-controlled randomized study

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 2, 2007, Pages 527-531

  Redman, Leanne M ^a   De Jonge, Lilian ^a   Fang, Xiaobing ^a   Gamlin, Betsy ^b   Recker, David ^b   Greenway, Frank L ^a   Smith, Steven R ^a   Ravussin, Eric ^a,c  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b TAKEDA PHARMACEUTICALS   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [[[[ (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1H INDOL 7 YLOXY] ACETIC ACID; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; FATTY ACID; GLUCOSE; INSULIN; PLACEBO; TAK 677; UNCLASSIFIED DRUG;

ABDOMINAL FAT; ABDOMINAL PAIN; ADULT; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENERGY EXPENDITURE; ENERGY METABOLISM; FEMALE; HEADACHE; HEART PALPITATION; HEART RATE; HERPES SIMPLEX; HORMONE BLOOD LEVEL; HOT FLUSH; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; METABOLISM; NAUSEA; NAUSEA AND VOMITING; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY QUOTIENT; SEX RATIO; SINUS CONGESTION; WEAKNESS;

EID: 33846961446     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-1740     Document Type: Article

References (16)

1. Arch JR 2002 β3-Adrenoceptor agonists: potential, pitfalls and progress. Eur J Pharmacol 440:99-107
2. Foster DO, Frydman ML 1978 Nonshivering thermogenesis in the rat. II. Measurements of blood flow with microspheres point to brown adipose tissue as the dominant site of the calorigenesis induced by noradrenaline. Can J Physiol Pharmacol 56:110-122
3. Havel RJ, Carlson LA, Ekelund LG, Holmgren A 1964 Studies on the relation between mobilization of free fatty acids and energy metabolism in man: effects of norepinephrine and nicotinic acid. Metabolism 13:1402-1412
4. Schiffelers SL, Brouwer EM, Saris WH, van Baak MA 1998 Inhibition of lipolysis reduces β1-adrenoceptor-mediated thermogenesis in man. Metabolism 47:1462-1467
5. Astrup A, Bulow J, Madsen J, Christensen NJ 1985 Contribution of BAT and skeletal muscle to thermogenesis induced by ephedrine in man. Am J Physiol 248:E507-E515
6. Arch JR, Ainsworth AT, Ellis RD, Piercy V, Thody VE, Thurlby PL, Wilson C, Wilson S, Young P 1984 Treatment of obesity with thermogenic β-adrenoceptor agonists: studies on BRL 26830A in rodents. Int J Obes 8(Suppl 1):1-11
7. Cawthorne MA, Carroll MJ, Levy AL, Lister CA, Sennitt MV, Smith SA, Young P 1984 Effects of novel β-adrenoceptor agonists on carbohydrate metabolism: relevance for the treatment of non-insulin-dependent diabetes. Int J Obes 8(Suppl 1):93-102
8. Francke S 2002 TAK-677 (Dainippon/Takeda). Curr Opin Invest Drugs 3:1624-1628
9. Harada H, Hirokawa Y, Suzuki K, Hiyama Y, Oue M, Kawashima H, Kato H, Yoshida N, Furutani Y, Kato S 2005 Discovery of a novel and potent human and rat β3-adrenergic receptor agonist, [3-[(2R)-[[(2R)-(3-chlorophenyl)-2- hydroxyethyl]amino]propyl]-1H-indol-7-y loxy]acetic acid. Chem Pharm Bull (Tokyo) 53:184-198
10. Kato H, Ohue M, Kato K, Nomura A, Toyosawa K, Furutani Y, Kimura S, Kadowaki T 2001 Mechanism of amelioration of insulin resistance by β3-adrenoceptor agonist AJ-9677 in the KK-Ay/Ta diabetic obese mouse model. Diabetes 50:113-122
11. Sugimoto T, Ogawa W, Kasuga M, Yokoyama Y 2005 Chronic effects of AJ-9677 on energy expenditure and energy source utilization in rats. Eur J Pharmacol 519:135-145
12. Weyer C, Tataranni PA, Snitker S, Danforth Jr E, Ravussin E 1998 Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective β3-adrenoceptor agonist in humans. Diabetes 47:1555-1561
13. Smith SR, Lovejoy JC, Greenway F, Ryan D, deJonge L, de la Bretonne J, Volafova J, Bray GA 2001 Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism 50:425-435
14. Nguyen T, de Jonge L, Smith SR, Bray GA 2003 Chamber for indirect calorimetry with accurate measurement and time discrimination of metabolic plateaus of over 20 min. Med Biol Eng Comput 41:572-578
15. de Jonge L, Nguyen T, Smith SR, Zachwieja JJ, Roy HJ, Bray GA 2001 Prediction of energy expenditure in a whole body indirect calorimeter at both low and high levels of physical activity. Int J Obes Relat Metab Disord 25:929-934
16. Thomas RF, Holt BD, Schwinn DA, Liggett SB 1992 Long-term agonist exposure induces upregulation of β3-adrenergic receptor expression via multiple cAMP response elements. Proc Natl Acad Sci USA 89:4490-4494